Adma Biologics reported $17.75M in Selling and Administration Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Adamis Pharmaceuticals ADMP:US USD 2.51M 1.7M
Adma Biologics ADMA:US USD 17.75M 1.86M
Agile Therapeutics AGRX:US USD 8.38M 2.06M
Alnylam Pharmaceuticals ALNY:US USD 235.86M 65.88M
Biocryst Pharmaceuticals BCRX:US USD 36.92M 1.1M
Dynavax Technologies DVAX:US USD 32.04M 3.69M
Minerva Neurosciences NERV:US USD 2.84M 6.57K
Novavax NVAX:US USD 122.88M 14.72M
Omeros OMER:US USD 12.2M 1.72M
Takeda 4502:JP JPY 262.3B 13.57B